LTRN vs PCG · $35.1M cap vs P/E 13, rev $12.78B
Lantern Pharma Inc (LTRN) versus PG&E Corp (PCG) — a side-by-side from cached financials, not a winner call.
Lantern Pharma Inc (LTRN) is a biotechnology company listed on US.
PG&E Corp (PCG) is a utilities - regulated electric company listed on US.
LTRN does not have a complete income-statement cache yet.
Latest reported PCG revenue for 2026-06-30 was $12.78B. Net income was $1.65B. Revenue was up 85.8% from 2026-03-31 to 2026-06-30. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
LTRN currently screens at market cap $35.1M. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
Not investment advice. Open the LTRN and PCG stock pages for the full models.
Not investment advice.